Cargando…
Cardiovascular effects associated with chimeric antigen receptor T cell therapy in cancer patients: A meta-analysis
BACKGROUND: Although numerous studies confirmed the marked efficacy of chimeric antigen receptor T cells (CAR-T cells) in many hematologic malignancies, severe cardiovascular toxicities remain to be a major obstacle when incorporating this technology. Furthermore, previous individual investigations...
Autores principales: | Chen, Li-Rong, Li, Ya-Jia, Zhang, Zheng, Wang, Ping, Zhou, Tao, Qian, Kai, Fan, Yu-Xin, Guo, Yu, He, Gong-Hao, Shen, Lei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9682079/ https://www.ncbi.nlm.nih.gov/pubmed/36439485 http://dx.doi.org/10.3389/fonc.2022.924208 |
Ejemplares similares
-
Chimeric Antigen Receptors for T-Cell Malignancies
por: Scherer, Lauren D., et al.
Publicado: (2019) -
Characterization of the Therapeutic Effects of Novel Chimeric Antigen Receptor T Cells Targeting CD38 on Multiple Myeloma
por: Li, Xiaorui, et al.
Publicado: (2021) -
The risk factors and early predictive model of hematotoxicity after CD19 chimeric antigen receptor T cell therapy
por: Wang, Yang, et al.
Publicado: (2022) -
Chimeric antigen receptor T-cell therapy for T-ALL and AML
por: Wei, Wenwen, et al.
Publicado: (2022) -
Special Chimeric Antigen Receptor (CAR) Modifications of T Cells: A Review
por: Miao, Lele, et al.
Publicado: (2022)